Members |
targetComponentId |
Clindamycin palmitate hydroc 75mg/5mL solution |
Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension |
Clindamycin phosphate 1% solution |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
Clindamycin phosphate 100mg vaginal ovule |
Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug) |
Clindamycin phosphate 10mg solution |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
Clindamycin phosphate 10mg/mL solution |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
Clindamycin phosphate 2% cream |
Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress score |
Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress total score |
Clinical X-ray application NOS |
Imaging (procedure) |
Clinical X-ray application NOS |
Imaging (procedure) |
Clinical actions A - G |
Action |
Clinical actions A-O |
Action |
Clinical actions H - O |
Action |
Clinical actions P - S |
Action |
Clinical actions P-Z |
Action |
Clinical actions T - Z |
Action |
Clinical allergy service |
Clinical allergy service |
Clinical cytogenetics service |
Clinical cytogenetics service (qualifier value) |
Clinical finding |
Clinical finding (finding) |
Clinical genetics service |
Clinical genetics service (qualifier value) |
Clinical immunology service |
Clinical immunology service |
Clinical management plan |
Clinical management plan |
Clinical molecular genetics service |
Clinical molecular genetics service (qualifier value) |
Clinical neurophysiology service |
Clinical neurophysiology service |
Clinical stage 0 |
American Joint Committee on Cancer stage 0 (qualifier value) |
Clinical stage I A |
American Joint Committee on Cancer stage IA (qualifier value) |
Clinical stage I B |
American Joint Committee on Cancer stage IB (qualifier value) |
Clinical stage I C |
American Joint Committee on Cancer stage IC (qualifier value) |
Clinical stage I E |
American Joint Committee on Cancer stage IE (qualifier value) |
Clinical stage I S |
American Joint Committee on Cancer stage IS (qualifier value) |
Clinical stage II A |
American Joint Committee on Cancer stage IIA (qualifier value) |
Clinical stage II B |
American Joint Committee on Cancer stage IIB (qualifier value) |
Clinical stage II C |
American Joint Committee on Cancer stage IIC (qualifier value) |
Clinical stage II E |
American Joint Committee on Cancer stage IIE (qualifier value) |
Clinical stage III A |
American Joint Committee on Cancer stage IIIA (qualifier value) |
Clinical stage III B |
American Joint Committee on Cancer stage IIIB (qualifier value) |
Clinical stage III C |
American Joint Committee on Cancer stage IIIC (qualifier value) |
Clinical stage IV A |
American Joint Committee on Cancer stage IVA (qualifier value) |
Clinical stage IV B |
American Joint Committee on Cancer stage IVB (qualifier value) |
Clinical stage IV C |
American Joint Committee on Cancer stage IVC (qualifier value) |
Clinically relevant enzymes with no Enzyme Commission designation |
Enzyme |
Clipping of organ NOC |
Closure by clip |
Clivogram |
Plain X-ray of clivus |
Clomocycline sodium adverse reaction |
Adverse reaction to clomocycline |
Clonazepam 0.125mg wafer |
Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug) |
Clonazepam 0.25mg wafer |
Clonazepam 250 microgram orodispersible tablet |
Clonazepam 0.5mg wafer |
Clonazepam 500 microgram orodispersible tablet |
Clonazepam 1mg wafer |
Clonazepam 1 mg orodispersible tablet |
Clonazepam 2mg wafer |
Clonazepam 2 mg orodispersible tablet |
Clopidogrel bisulfate 75mg tablet |
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug) |
Clorazepate dipotassium 7.5mg |
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
Closed anterior dislocation of humerus |
Closed anterior dislocation of glenohumeral joint |
Closed cardiac massage alone |
Manual external cardiac massage with closed chest |
Closed cardiac massage alone |
Manual external cardiac massage with closed chest |
Closed cerebral contusion |
Contusion of cerebral cortex |
Closed fracture finger metacarpal shaft |
Closed fracture of shaft of metacarpal bone |
Closed fracture of C1-C4 level with central cord syndrome |
Central cord syndrome of cervical spinal cord due to closed fracture at C1-C4 level (disorder) |
Closed fracture of C1-C4 level with other specified spinal cord injury |
Closed fracture of C1-C4 level with spinal cord injury |
Closed fracture of C5-C7 level with central cord syndrome |
Central cord syndrome of cervical spinal cord due to closed fracture at C5-C7 level (disorder) |
Closed fracture of C5-C7 level with other specified spinal cord injury |
Closed fracture of C5-C7 level with spinal cord injury |
Closed fracture of T1-T6 level with central cord syndrome |
Central cord syndrome of thoracic spinal cord due to closed fracture at T1-T6 level (disorder) |
Closed fracture of T1-T6 level with other specified spinal cord injury |
Closed fracture of T1-T6 level with spinal cord injury |
Closed fracture of T7-T12 level with central cord syndrome |
Central cord syndrome of thoracic spinal cord due to closed fracture at T7-T12 level (disorder) |
Closed fracture of T7-T12 level with other specified spinal cord injury |
Closed fracture of T7-T12 level with spinal cord injury |
Closed fracture of base of skull with intracranial injury of other and unspecified nature |
Closed fracture of base of skull with intracranial injury |
Closed fracture of base of skull with other and unspecified intracranial hemorrhage |
Closed fracture of base of skull with intracranial hemorrhage |
Closed fracture of bony thorax part unspecified |
Closed fracture of bones of trunk |
Closed fracture of bony thorax part unspecified |
Closed fracture of bones of trunk |
Closed fracture of cervical region with spinal cord injury |
Injury of cervical spinal cord due to closed fracture of cervical spine (disorder) |
Closed fracture of cervical spine with cord lesion |
Injury of cervical spinal cord due to closed fracture of cervical spine (disorder) |
Closed fracture of cervical spine with spinal cord lesion NOS |
Injury of cervical spinal cord due to closed fracture of cervical spine (disorder) |
Closed fracture of coccyx with spinal cord lesion |
Closed fracture of coccyx |
Closed fracture of lower limb, level unspecified |
Closed fracture of lower limb |
Closed fracture of lower limb, level unspecified |
Closed fracture of lower limb |
Closed fracture of other parts of bony thorax |
Closed fracture of bones of trunk |
Closed fracture of other parts of bony thorax |
Closed fracture of bones of trunk |
Closed fracture of sacrum and coccyx with other cauda equina injury |
Cauda equina injury co-occurrent and due to closed fracture of sacrum AND/OR coccyx (disorder) |
Closed fracture of sacrum and coccyx with other spinal cord injury |
Closed fracture of coccyx |
Closed fracture of sacrum with spinal cord lesion |
Closed fracture sacrum |
Closed fracture of sacrum without spinal cord injury |
Closed fracture sacrum |
Closed fracture of tibia and fibula, unspecified part |
Closed fracture of lower leg (disorder) |
Closed fracture of tibia and fibula, unspecified part, NOS |
Closed fracture of lower leg (disorder) |
Closed fracture of tibia and fibula, unspecified part, NOS |
Closed fracture of lower leg (disorder) |
Closed fracture of unspecified bone of lower limb |
Closed fracture of lower limb |
Closed fracture of vault of skull with intracranial injury of other and unspecified nature |
Closed fracture vault of skull with intracranial injury |
Closed fracture of vault of skull with other and unspecified intracranial hemorrhage |
Closed fracture of vault of skull with intracranial hemorrhage |
Closed fracture pelvis, single pubic ramus |
Closed fracture of pubic ramus |
Closed fracture proximal femur, other transcervical |
Closed fracture of midcervical section of femur |
Closed fracture proximal femur, transcervical, not otherwise specified |
Closed fracture of midcervical section of femur |
Closed hindbrain contusion |
Contusion of hindbrain |
Closed ill-defined fractures of upper limb |
Closed fracture of multiple bones of upper limb |
Closed inferior dislocation of humerus |
Closed inferior dislocation of glenohumeral joint (disorder) |
Closed posterior dislocation of humerus |
Closed posterior dislocation of glenohumeral joint (disorder) |
Closed reduction and application of cast or splint |
Closed reduction of fracture AND application of cast |
Closed reduction of fracture of zygoma AND/OR zygomatic arch |
Closed reduction of fracture of zygomatic bone (procedure) |
Closed reduction of vertebral process fracture |
Closed reduction of fracture of vertebra |
Closed skull fracture with intracranial injury of other and unspecified nature |
Closed skull fracture with intracranial injury |
Closed skull fracture with other and unspecified intracranial hemorrhage |
Closed skull fracture with intracranial haemorrhage |
Closed spinal dislocation with anterior thoracic cord lesion |
Anterior lesion of thoracic spinal cord due to closed dislocation of joint of thoracic spine (disorder) |
Closed spinal dislocation with central cervical cord lesion |
Central cord syndrome of cervical spinal cord due to closed dislocation of cervical spine (disorder) |
Closed spinal dislocation with central lumbar cord lesion |
Central cord syndrome of lumbar spinal cord due to closed spinal dislocation (disorder) |
Closed spinal dislocation with central thoracic cord lesion |
Central cord syndrome of thoracic spinal cord due to closed dislocation of joint of thoracic spine (disorder) |